Insulin aspart, recombinant Subcutaneous and Simvastatin Oral Suspension
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Simvastatin Oral Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: simvastatin
Brand name: Zocor, Flolipid
Synonyms: Simvastatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Simvastatin orally disintegrating tablet
- Insulin aspart, recombinant Subcutaneous-Simvastatin Tablets
- Insulin aspart, recombinant Subcutaneous-Sinarest
- Insulin aspart, recombinant Subcutaneous-Sinarest Nasal
- Insulin aspart, recombinant Subcutaneous-Sinarest Sinus
- Insulin aspart, recombinant Subcutaneous-Sine-Off Maximum Strength
- Simvastatin Oral Suspension-Insulin degludec
- Simvastatin Oral Suspension-Insulin Degludec (U-100) Prefilled Pens
- Simvastatin Oral Suspension-Insulin Degludec (U-100) Vials
- Simvastatin Oral Suspension-Insulin Degludec (U-200) Prefilled Pens
- Simvastatin Oral Suspension-Insulin degludec and liraglutide
- Simvastatin Oral Suspension-Insulin degludec and liraglutide Subcutaneous